analyse_media
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

"LDL cholesterol" AND "cardiovascular risk"

Now let me put this together into a clear clinical summary.

Summary of Abnormal Findings

This report shows several clusters of abnormalities. Here's what each means:

πŸ”΄ Lipid Panel - Most Significant Concern

TestValueReferenceComment
LDL Cholesterol180 mg/dL<100Markedly elevated
Total Cholesterol237 mg/dL<200High
Non-HDL Cholesterol200.3 mg/dL<160High
HDL Cholesterol37 mg/dL40-60Low
TC/HDL Ratio6.43-5Elevated
LDL/HDL Ratio4.91.5-3.5Elevated
Trig/HDL Ratio3.25<3.12Slightly high
This is a classic atherogenic dyslipidemia pattern: high LDL, low HDL, unfavorable ratios. LDL-C is the primary treatment target in most guidelines (Henry's Clinical Diagnosis and Management by Laboratory Methods, p. 2825-2835), and a large body of meta-analytic evidence confirms that lowering LDL reduces cardiovascular event risk in a dose- and duration-dependent manner (Burger et al., 2024 meta-analysis of 60 RCTs, PMID 39126771). Combined with the mildly elevated hs-CRP below, this profile suggests meaningfully increased atherosclerotic cardiovascular disease (ASCVD) risk that generally warrants dietary/lifestyle intervention and a discussion with a physician about statin therapy.

🟠 Cardiac Risk Marker

  • hs-CRP 3.7 mg/L (ref <3): Mildly elevated, indicating low-grade systemic inflammation. In cardiovascular risk stratification, hs-CRP >3 mg/L is considered "high risk" category (Robbins & Cotran, Pathologic Basis of Disease, p. 2842). It's a nonspecific marker (can rise with infection, obesity, smoking) but combined with your lipid pattern, it reinforces the need for cardiovascular risk attention.

🟠 Diabetes Screening

  • HbA1c 5.8% (ref <5.7%): Falls in the prediabetes range (5.7-6.4%). This warrants lifestyle modification (diet, exercise, weight management) and periodic rechecking, as annual progression risk to diabetes increases with rising HbA1c (Symptom to Diagnosis, p. 9668).

🟑 Complete Blood Count

  • Hematocrit 52.9% (ref 40-50%): Elevated - can reflect dehydration/hemoconcentration or, if persistent, warrants evaluation for polycythemia.
  • MCHC 31.4 g/dL (ref 31.5-34.5): Marginally low.
  • RDW-SD 50.5 fL (ref 39-46): Elevated, meaning your red blood cells show more size variation (anisocytosis) than normal. This can be seen with early iron, B12, or folate deficiency, or with reticulocytosis (Goldman-Cecil Medicine, p. 2423-2438). Your low B12 below is a plausible contributor.

🟑 Vitamins

  • Vitamin B-12: 165 pg/mL (ref 197-771): Low/deficient. B12 deficiency can cause macrocytic (megaloblastic) anemia and, importantly, neurological symptoms (numbness, tingling, gait problems, cognitive changes) that can precede any blood count changes (Textbook of Family Medicine, p. 489-492; Robbins Basic Pathology, p. 2008). This deserves clinical follow-up (dietary history, consider intrinsic factor/pernicious anemia workup, B12 supplementation).
  • Vitamin D (Total): 28.3 ng/mL (ref 30-100): Mildly insufficient - common and usually managed with supplementation and sun exposure.

🟒 Electrolytes

  • Sodium: 134.17 mmol/L (ref 136-145): Mild hyponatremia - low-grade, could relate to hydration status, diet, or other factors; usually rechecked rather than acted on immediately if isolated and mild.

🟒 Renal Panel

  • BUN (5.9), BUN/Creatinine ratio (8.43), Creatinine (0.7), and calculated Urea (12.63) are all slightly below the lower reference limit. Low BUN/urea can reflect low protein intake, good hydration, liver issues, or pregnancy - generally not concerning in isolation, especially with normal-low creatinine suggesting good kidney filtration/muscle mass.

🟒 Liver

  • Serum Globulin: 3.41 g/dL (ref 2.5-3.4): Just barely above range - not clinically significant alone; if albumin/total protein were also reported, an albumin/globulin ratio would help contextualize this.

Bottom Line

The two findings that matter most clinically are:
  1. Significant LDL-driven dyslipidemia (high LDL/total cholesterol, low HDL, adverse ratios) plus mildly elevated hs-CRP - together these raise cardiovascular risk and are the priority to discuss with a doctor (consider fasting confirmation, ASCVD risk calculator, lifestyle changes, +/- statin).
  2. Prediabetes-range HbA1c and B12 deficiency - both are actionable with lifestyle changes/supplementation and worth discussing with your physician, along with the mild anemia-pattern changes (high RDW, borderline MCHC).
None of these values individually are emergencies, but the combination (dyslipidemia + inflammation marker + prediabetes) forms a metabolic risk pattern worth addressing proactively. I'd recommend sharing this full panel with your physician for a tailored plan, since these findings interact with your broader history (weight, blood pressure, family history, medications) that I don't have visibility into.
Note: I could not directly re-view the image file itself due to a technical access issue, but the complete table data was already provided in readable text form, which I used for this analysis.
This is a shared conversation. Sign in to Orris to start your own chat.